Nab-paclitaxel/gemcitabine first line therapy in patients with metastatic pancreatic carcinoma and high-bilirubin values: data from the German QoliXane pancreatic cancer registry
© The Author 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissionsoup.com.Background: Hyperbilirubinaemia is a common disease effect in patients (pts) with metastatic pancreatic canc...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
11 October 2016
|
| In: |
Annals of oncology
Year: 2016, Jahrgang: 27 |
| ISSN: | 1569-8041 |
| DOI: | 10.1093/annonc/mdw371.76 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1093/annonc/mdw371.76 Verlag, kostenfrei, Volltext: https://academic.oup.com/annonc/article/27/suppl_6/684P/2799431 
|
| Verfasserangaben: | G. zur Hausen, O. Waidmann, M.A. Woerns, H.G. Hoeffkes, S. Doerfel, M.O. Zahn, A. Aldaoud, M. Stauch, C. Springfeld, N. Haertel, A. Reichart, T.O. Goetze, S. Schwarz, C. Pauligk, J. Roemmler-Zehrer, R.D. Hofheinz, S.-E. Al-Batran |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1565372972 | ||
| 003 | DE-627 | ||
| 005 | 20230427142115.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 171115s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/annonc/mdw371.76 |2 doi | |
| 035 | |a (DE-627)1565372972 | ||
| 035 | |a (DE-576)495372978 | ||
| 035 | |a (DE-599)BSZ495372978 | ||
| 035 | |a (OCoLC)1340982151 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Hausen, Gerrit zur |e VerfasserIn |0 (DE-588)1144397804 |0 (DE-627)1004724349 |0 (DE-576)495372862 |4 aut | |
| 245 | 1 | 0 | |a Nab-paclitaxel/gemcitabine first line therapy in patients with metastatic pancreatic carcinoma and high-bilirubin values |b data from the German QoliXane pancreatic cancer registry |c G. zur Hausen, O. Waidmann, M.A. Woerns, H.G. Hoeffkes, S. Doerfel, M.O. Zahn, A. Aldaoud, M. Stauch, C. Springfeld, N. Haertel, A. Reichart, T.O. Goetze, S. Schwarz, C. Pauligk, J. Roemmler-Zehrer, R.D. Hofheinz, S.-E. Al-Batran |
| 264 | 1 | |c 11 October 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 15.11.2017 | ||
| 520 | |a © The Author 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissionsoup.com.Background: Hyperbilirubinaemia is a common disease effect in patients (pts) with metastatic pancreatic cancer (mPC). As clinical trials often exclude them, data on management of these pts are rare. In the framework of a German observational multicenter study (QoliXane), quality of life and therapy data are currently being collected in pts with mPC receiving a combination of nab-paclitaxel and gemcitabine. This is an interim analysis on hyperbilirubinaemia management.Methods: Pts were included to this analysis if they entered the trial with a bilirubin level ≥ 1.2 mg/dl and completed at least 2 cycles. Bilirubin levels were documented for up to 4 cycles and methods of hyperbilirubinaemia management have been assessed. A both descriptive and explorative analysis was performed using IBM SPSS V 23.Results:... | ||
| 700 | 1 | |a Springfeld, Christoph |d 1972- |e VerfasserIn |0 (DE-588)123388910 |0 (DE-627)706281039 |0 (DE-576)293689385 |4 aut | |
| 700 | 1 | |a Härtel, Nicolai |d 1977- |e VerfasserIn |0 (DE-588)129912913 |0 (DE-627)483650609 |0 (DE-576)297899821 |4 aut | |
| 700 | 1 | |a Hofheinz, Ralf-Dieter |d 1969- |e VerfasserIn |0 (DE-588)121917517 |0 (DE-627)08161876X |0 (DE-576)292991568 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of oncology |d Amsterdam [u.a.] : Elsevier, 1990 |g 27(2016,Supplement 6) Artikel-Nummer 684P, 1 Seite |h Online-Ressource |w (DE-627)320428796 |w (DE-600)2003498-2 |w (DE-576)098134345 |x 1569-8041 |7 nnas |a Nab-paclitaxel/gemcitabine first line therapy in patients with metastatic pancreatic carcinoma and high-bilirubin values data from the German QoliXane pancreatic cancer registry |
| 773 | 1 | 8 | |g volume:27 |g year:2016 |g supplement:Supplement |a Nab-paclitaxel/gemcitabine first line therapy in patients with metastatic pancreatic carcinoma and high-bilirubin values data from the German QoliXane pancreatic cancer registry |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/annonc/mdw371.76 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://academic.oup.com/annonc/article/27/suppl_6/684P/2799431 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20171115 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 121917517 |a Hofheinz, Ralf-Dieter |m 121917517:Hofheinz, Ralf-Dieter |d 60000 |d 61200 |e 60000PH121917517 |e 61200PH121917517 |k 0/60000/ |k 1/60000/61200/ |p 16 | ||
| 998 | |g 129912913 |a Härtel, Nicolai |m 129912913:Härtel, Nicolai |d 60000 |d 61200 |e 60000PH129912913 |e 61200PH129912913 |k 0/60000/ |k 1/60000/61200/ |p 10 | ||
| 998 | |g 123388910 |a Springfeld, Christoph |m 123388910:Springfeld, Christoph |d 910000 |d 910100 |e 910000PS123388910 |e 910100PS123388910 |k 0/910000/ |k 1/910000/910100/ |p 9 | ||
| 999 | |a KXP-PPN1565372972 |e 2987237278 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedDisp":"11 October 2016","dateIssuedKey":"2016"}],"recId":"1565372972","id":{"doi":["10.1093/annonc/mdw371.76"],"eki":["1565372972"]},"note":["Gesehen am 15.11.2017"],"relHost":[{"pubHistory":["1.1990 -"],"language":["eng"],"part":{"volume":"27","text":"27(2016,Supplement 6) Artikel-Nummer 684P, 1 Seite","year":"2016"},"title":[{"title":"Annals of oncology","subtitle":"official journal of the European Society for Medical Oncology","title_sort":"Annals of oncology"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"1990-","publisher":"Elsevier ; Kluwer ; Oxford Univ. Press","dateIssuedKey":"1990","publisherPlace":"Amsterdam [u.a.] ; Dordrecht [u.a.] ; Oxford"}],"recId":"320428796","note":["Gesehen am 12.11.20","Ungezählte Beil.: Supplement"],"corporate":[{"role":"isb","display":"European Society for Medical Oncology"}],"physDesc":[{"extent":"Online-Ressource"}],"disp":"Nab-paclitaxel/gemcitabine first line therapy in patients with metastatic pancreatic carcinoma and high-bilirubin values data from the German QoliXane pancreatic cancer registryAnnals of oncology","id":{"eki":["320428796"],"issn":["1569-8041"],"zdb":["2003498-2"]}}],"title":[{"title_sort":"Nab-paclitaxel/gemcitabine first line therapy in patients with metastatic pancreatic carcinoma and high-bilirubin values","title":"Nab-paclitaxel/gemcitabine first line therapy in patients with metastatic pancreatic carcinoma and high-bilirubin values","subtitle":"data from the German QoliXane pancreatic cancer registry"}],"name":{"displayForm":["G. zur Hausen, O. Waidmann, M.A. Woerns, H.G. Hoeffkes, S. Doerfel, M.O. Zahn, A. Aldaoud, M. Stauch, C. Springfeld, N. Haertel, A. Reichart, T.O. Goetze, S. Schwarz, C. Pauligk, J. Roemmler-Zehrer, R.D. Hofheinz, S.-E. Al-Batran"]},"language":["eng"],"person":[{"family":"Hausen","display":"Hausen, Gerrit zur","given":"Gerrit zur","role":"aut"},{"display":"Springfeld, Christoph","role":"aut","given":"Christoph","family":"Springfeld"},{"display":"Härtel, Nicolai","given":"Nicolai","role":"aut","family":"Härtel"},{"family":"Hofheinz","given":"Ralf-Dieter","role":"aut","display":"Hofheinz, Ralf-Dieter"}]} | ||
| SRT | |a HAUSENGERRNABPACLITA1120 | ||